US FDA consults on proposals to regulate mobile medical apps
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has issued its much-awaited draft guidance on how it intends to regulate certain mobile medical applications that are designed for use on smartphones and other mobile computing devices1,2.